Circulating microRNAs as potential new biomarkers for prostate cancer

Changes in circulating microRNA levels associated with prostate cancer

(2012) R J Bryant et al.   BRITISH JOURNAL OF CANCER

Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer

(2012) Claire E. Fletcher et al.   HUMAN MOLECULAR GENETICS

A panel of five circulating microRNAs as potential biomarkers for prostate cancer

(2012) Zhang-Hui Chen et al.   PROSTATE

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

(2012) Jing Shen et al.   PROSTATE

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

(2011) Jason C. Gonzales et al.   Clinical Genitourinary Cancer

Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

(2011) Luke A. Selth et al.   INTERNATIONAL JOURNAL OF CANCER

Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma

(2011) J. Szczyrba et al.   MOLECULAR CANCER RESEARCH

MicroRNAs in body fluids—the mix of hormones and biomarkers

(2011) Maria Angelica Cortez et al.   Nature Reviews Clinical Oncology

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

(2011) Fulya Yaman Agaoglu et al.   TUMOR BIOLOGY

Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer

(2011) Robert Mahn et al.   UROLOGY

Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients

(2010) Felix Moltzahn et al.   CANCER RESEARCH

MiRNAs as biomarkers and therapeutic targets in cancer☆

(2010) Helen M Heneghan et al.   CURRENT OPINION IN PHARMACOLOGY

Circulating miRNAs are correlated with tumor progression in prostate cancer

(2010) Jan C. Brase et al.   INTERNATIONAL JOURNAL OF CANCER

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)

(2010) Evan M. Kroh et al.   METHODS

miRBase: integrating microRNA annotation and deep-sequencing data

(2010) A. Kozomara et al.   NUCLEIC ACIDS RESEARCH

Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells

(2010) Lucy Pigati et al.   PLoS One

Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy

(2010) Hai-Liang Zhang et al.   PROSTATE

Androgen regulation of micro-RNAs in prostate cancer

(2010) Kati K. Waltering et al.   PROSTATE

Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer

(2009) Fritz H Schröder et al.   CURRENT OPINION IN UROLOGY

Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray

(2009) Michael J. Lodes et al.   PLoS One

MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin

(2008) Tao Liu et al.   CANCER LETTERS

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

(2008) Douglas D. Taylor et al.   GYNECOLOGIC ONCOLOGY

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA